To Identify Potential New Urine Marker Panel for Cancer Screening

Launched by CHINESE UNIVERSITY OF HONG KONG · Dec 27, 2020

Keywords

ClinConnect Summary

This clinical trial is looking into a new way to detect cancer by analyzing urine samples for substances called polyamines. Polyamines are natural chemicals made by our bodies, and researchers believe that their levels in urine might change in people with cancer. The goal of this study is to see if measuring these substances can help doctors diagnose common types of cancer more accurately.

To participate in the trial, you need to be at least 18 years old. If you have cancer, you should have a confirmed diagnosis from a doctor. If you do not have cancer, your medical records should show that you are healthy. However, if you've had a urinary tract infection or certain medical procedures in the past six weeks, you won't be eligible to join. Participants will provide urine samples, and their health information will be kept private. This study is currently looking for volunteers, and everyone is welcome to apply, regardless of gender.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adult patients with age \> 18 years old.
• • 2. For cancer patients, a histological diagnosis of cancer is available.
• • 3. For normal control, there is no diagnosis of cancer in the medical record.
• Exclusion Criteria:
• • 1. Patient with recent urinary tract infection within 6 weeks prior to urine collection.
• • 2. Patient with recent urethral instrumentation, such as Foley catheter insertion, cystoscopy etc, within 6 weeks prior to urine collection.
• • 3. Patient refused or unable to provide consent for the study